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A wide variety of 1) parametric regression models and 2) co-expression networks have
been developed for finding gene-by-gene interactions underlying complex traits from
expression data. While both methodological schemes have their own well-known benefits,
little is known about their synergistic potential. Our study introduces their methodological
fusion that cross-exploits the strengths of individual approaches via a built-in information-
sharing mechanism. This fusion is theoretically based on certain trait-conditioned depen-
dency patterns between two genes depending on their role in the underlying parametric
model. Resulting trait-specific co-expression network estimation method 1) serves to
enhance the interpretation of biological networks in a parametric sense, and 2) exploits the
underlying parametric model itself in the estimation process. To also account for the sub-
stantial amount of intrinsic noise and collinearities, often entailed by expression data, a tai-
lored co-expression measure is introduced along with this framework to alleviate related
computational problems. A remarkable advance over the reference methods in simulated
scenarios substantiate the method’s high-efficiency. As proof-of-concept, this synergistic
approach is successfully applied in survival analysis, with acute myeloid leukemia data, fur-
ther highlighting the framework’s versatility and broad practical relevance.
Author summary
Here we built up a mathematically justified bridge between 1) parametric approaches and
2) co-expression networks in light of identifying molecular interactions underlying com-
plex traits. We first shared our concern that methodological improvements around these
schemes, adjusting only their power and scalability, are bounded by more fundamental
scheme-specific limitations. Subsequently, our theoretical results were exploited to over-
come these limitations to find gene-by-gene interactions neither of which can capture
alone. We also aimed to illustrate how this framework enables the interpretation of co-
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Software and simulated replicates are presented in
expression networks in a more parametric sense to achieve systematic insights into com-
plex biological processes more reliably. The main procedure was fit for various types of
biological applications and high-dimensional data to cover the area of systems biology as
broadly as possible. In particular, we chose to illustrate the method’s applicability for
gene-profile based risk-stratification in cancer research using public acute myeloid leuke-
mia datasets.
This is a PLOS Computational Biology Methods paper.
Introduction
Gene-by-gene interactions are known to underlie phenotypes in a variety of systems [1, 2]. A
huge amount of research has been devoted to robust identification of such components from
high-throughput biological data [3–5]. The development of this methodology is mainly
focused on exhaustive search approaches and implementing algorithms that alleviate their
computational complexities [4, 6, 7]. Typically, these methods are restricted into parametric
models consisting of overly simplified interactions types (e.g. product terms) contributing
additively to the phenotype [8]. However, gene-by-gene interactions are interpreted biologi-
cally more broadly than parametric models often allow, such as functional interactions
between genes in biological pathways [1, 2, 8, 9].
To identify functionally related genes or members of the same pathway from omics data,
one could benefit from the vast scheme of co-expression network analysis [10]. In co-expres-
sion networks, each node represents a single gene, and is connected with another nodes if the
expression values of the corresponding genes are dependent. In particular, there has been a
growing interest on estimating simultaneously two co-expression networks, such that the esti-
mation process accounts for some external state of interest [11–17]. For instance, in transcrip-
tional interactions, where a transcription factor binds to promoter regions of a particular gene
to regulate its expression levels, can be disrupted in cancers [12, 18]. Then co-expression net-
works estimated separately over case and control samples are expected to have interesting dif-
ferences due to the cancer-specific dysregulations in transcriptional mechanisms.
Co-expression networks can be estimated from data (in both case-control and single popu-
lations) either with unconditional or conditional dependency metrics. A popular uncondi-
tional approach is to measure, in all its simplicity, just a pairwise correlation/covariance
between genes [19–21]. However, this simple metric has received a lot of criticism for evaluat-
ing direct dependencies—false positive edges between genes might occur in the presence of
confounding factors [22, 23]. For this problem, inverse-covariance matrix based Gaussian
graphical models (GGMs) [24, 25] provide a complete solution, as they are capable of distin-
guishing direct relationships from indirect ones [26, 27].
These network comparison procedures are often motivated by the deficiencies of the
exhaustive search approaches. On the other hand, the current network approaches are lacking
some very crucial properties of the parametric interaction models in turn. These include, for
instance, an explicit connection with the trait of interest, intuitive parametric interpretations,
various options for hypothesis testing, and a possibility to account for the main effects. Despite
the popularity of differential co-expression network analyses, these critical issues have
remained unresolved.
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Little is also known about their synergistic potential in the search of molecular interactions
and pathways underlying complex traits. That is, a mathematical presentation, that would for-
malize the relationship between co-expression networks and parametric interaction models
remains undefined. Here we consider the issues above and characterize the relationship
between these methodological schemes. Finally, a methodological fusion is provided to cross-
exploit all scheme-specific strengths via a built-in information-sharing mechanism. As proof-
of-concept, the framework is applied for searching prognostically important gene-by-gene
interactions in acute myeloid leukemia (AML).
Results
Our approach combines the benefits of two popular methodological schemes, co-expression
networks [10], and parametric gene-by-gene interaction models [3, 4], to find molecular inter-
actions and pathways regulating complex traits neither of which can capture alone (Fig 1).
This is based on three simple steps:
• Step 1: A pre-defined underlying parametric regression model for trait variation is first used
to estimate such effects of genes that are not identifiable with co-expression networks (e.g.
the main effects). The remaining unexplainable variation is then subtracted from the original
trait variable and used as a new response variable for the next step.
• Step 2: The provided trait-specific co-expression network estimation method is then applied
to estimate network structures that can explain the trait variation remained from the first
step. A novel dependency metric is also provided to account for certain collinearities in data
that are generally considered problematic with the parametric methods used in the first step.
• Step 3: The underlying parametric model is then used again to provide a parametric inter-
pretation for the estimated co-expression network elements, which is not possible standalone
from the co-expression networks.
While a high number of co-expression techniques have been introduced over the last 20
years, and parametric regression model type approaches even longer, the synergistic potential
of these different schemes has remained unnoticed. The above three steps fuses these two
schemes into a one, easy-to-use model guided co-expression network estimation procedure, to
overcome the limitations of each. In particular, these model guided co-expression networks
are always response variable specific by the construction. This means that all relationship
between genes, whose interplay is not important for the response variable of interest, are
excluded from the resulting network. In advance of illustrating its usage in the simulated and
real examples, we briefly summarize these two schemes and outline the proposed fusion itself.
Fig 1. Schematic overview. A diagram of the conceptual entities of the proposed fusion (model guided co-expression
networks) combining two schemes—parametric interaction models and co-expression networks. The most central
methodological benefits (green checkmarks) and deficiencies (red X marks) are listed method-specifically.
https://doi.org/10.1371/journal.pcbi.1008960.g001
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Gene-by-gene interaction model
In a regular gene-by-gene interaction model, normally distributed (with zero means) expres-
sion levels of individual genes Xi1, . . ., Xip as well as the pairwise interactions between them are







XijXikbjk þ εi; ð1Þ
where εi �
i:i:d N ð0; s2Þ for all i = 1, . . ., n. Here μ is the population intercept and later assumed
to be zero, βj is the main effect of jth gene Xj and βjk is the effect of gene-by-gene interaction
term between genes Xj and Xk. A subindex i in each gene represents the expression value of the
corresponding gene measured from an individual i. In particular, we will refer to the interac-
tion terms of the model (1) as type I interactions.
Despite its popularity, this model ignores completely the complex gene-gene interactions
effects that do not contribute linearly to the phenotypic variation, e.g., through functional
interactions between genes in biological pathways [1, 2, 8, 9]. Therefore we formulate an exten-
sion of the model (1) involving more complex activation/deactivation patterns between gene-
expression levels that are associated only with either low or high phenotype values and less effi-
ciently identifiable with parametric interaction model (1). To model such effects, we use an
additional mapping Dð�; �Þ : R2 ! R which refers to an arbitrary gene activation/deactivation










ajkDjkðXij;XikÞ þ εi: ð2Þ
For instance, in transcriptional interactions where a transcription factor binds to promoter
regions of a particular gene to regulate its expression levels can be disrupted in cancers [12,
18]. Such gene-gene interactions Δjk(Xij, Xik) will be referred as type II interactions.
Co-expression networks
Generally, a probabilistic network G refers to a pair (V, E) of nodes V≔ {1, . . ., p} and the col-
lection E of edges connecting these individual nodes [24]. In co-expression networks, nodes
denote a set of random variables {X1, X2, . . ., Xp} that correspond to the expression levels of p
individual genes. The collection E of edges, in turn, represents a desired type of dependencies
between individual genes. The aim of the co-expression network inference is to estimate these
dependencies from data with a case-specifically chosen co-expression measure. For instance,
simple covariance or correlation coefficients are the most popular co-expression measures for
constructing co-expression networks as they are easy to estimate from data [10]. Alternatively,
if a random vector, representing the expression levels of p individual genes {X1, X2, . . ., Xp} (or
its normalized version) follows a multivariate normal distribution N ð0;SÞ, co-expression net-
works are often modeled with the inverse covariance matrix S−1 [24]. The latter is closely
related to Gaussian graphical models (GGMs) which are capable of distinguishing direct rela-
tionships between genes from indirect ones [24], and are referred as such in the forthcoming
sections.
Problems in interaction search and new perspectives
Since popular exhaustive search methods [3–5] focus on the model (1), they are incapable of
identifying type II interactions. These approaches are also often struggling with identifiability
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issues caused by strongly co-expressed genes. Such deficiencies may cause highly incomplete
and distorted conclusions about the role and proportion of gene-gene interactions in overall
trait regulation mechanisms. Consequences might be particularly adverse in medical applica-
tions, e.g., when designing personalized treatments based on gene expression profiling. Never-
theless, both of these deficiencies are stemming from the fact that exhaustive search
approaches are inefficient to account for the dependencies between genes.
In this regard, one could benefit from the vast co-expression network estimation methodol-
ogy [19–21, 24, 25] designed exactly for such purposes. On the other hand, co-expression net-
works, in turn, are not well-suited for explicitly modeling various types of effects on
phenotypic variation (e.g. the main or interaction effects) in comparison to the parametric
regression models. As such, an appropriately implemented hybrid perspective is required for
revealing interactions underlying complex traits efficiently. In the materials and methods sec-
tion, we contribute to this area by fusing the parametric interaction model (2) into the co-
expression network estimation in accordance to the following outline:
• Objective A: Incorporating the phenotypic information into the network estimation such
that the network represents only phenotypically important gene relationships.
• Objective B: Determining an explicit link between the concept of co-expression networks
and the generalized interaction model (2).
• Objective C: Exploiting the above link to derive a network estimation method in which type
I and type II interactions are separated in the estimation process.
• Objective D: Introducing an estimation metric that accounts for the common characteristics
of phenotype regulating mechanisms and expression data.
Now we have a framework for trait-specific co-expression network estimation based on
parallel consideration and exploitation of the underlying interaction model (2). Particularly,
this network provides evidence of gene-by-gene interactions (type I and II) in relation to the
underlying parametric interaction model, while the co-expression networks generally repre-
sent only associations between genes. Thus, the estimated network connections are referred as
interactions rather than associations in this context.
A technical overview of the procedure
Here we give an overview of each step of the proposed method (see also Fig 2) which is pre-
sented and explained comprehensively in the materials and methods section.
Step 1. Estimate the residual vector from the main effect model
As a partial solution to the objective (D), the main effects are first estimated in the model
(2) without the interaction terms to get the residual estimates




Individuals are then divided into the high and low groups based on the empirical quantiles
Qε̂iðaÞ and Qε̂ið1   aÞ (a 2 ]0, 0.5]) of the estimated residual values ε̂i and two separate
networks are estimated corresponding to these groups in the next step.
Step 2. Estimate the high and low networks
In this step, we first estimate two networks: A high network is constructed over individuals
in a high group, i.e., to whom ε̂i � Qε̂ið1   aÞ and a low network is estimated over
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individuals to whom ε̂i � Qε̂iðaÞ holds, respectively. To estimate the corresponding edge
weights by accounting for the objective (D), we propose a novel correlation measure and
compute the corresponding matrices Fa and F1−a in the low and high groups. These matri-
ces are then used to define a novel differential network structure Qa = |F1−a −Fa|, referred
as differential part-correlation co-expression network (dPCCN), which links this frame-
work to the objective (A).
Step 3. Link the estimated networks structures to the underlying parametric model
To further identify and separate type I and II interactions in the estimation process (objec-
tive C), we formulate its sign-adjusted version Qsgn,a, that uses a set of rules to characterize
each differential network element as negative, zero or positive. Each of them denotes a spe-
cific parametric interpretation, and builds up a connection between the differential network
elements and the effects in the parametric interaction model (2) as follows:
• (L1): If an individual network edge weight Qsgn,a(j, k)> 0, then the associated type I inter-
action effect βjk is non-zero in the model (2).
• (L2): If an individual network edge weight Qsgn,a(j, k)< 0, then the associated type II inter-
action effect αjk is non-zero in the model (2).
• (L3): If an individual network edge weight Qsgn,a(j, k) = 0, then both αjk and βjk are zero in
the model (2).
The R-code for this whole procedure and a step-by-step guidance for its usage is available
in S2 Appendix (See also Fig 2). In particular, the only parameter (by default) left for users to
be specified case-specifically is the threshold parameter r. This is considered later in more
detail.
Fig 2. Procedural workflow diagram. A schematic representation of the logical structure underlying the provided
algorithmic implementation. The first panel from the top represents the empirical density function of the residual
vector estimated from the main effect model. Here Q(�) is a quantile function of this distribution and a 2 [0.5, 1[ is a
user-defined cut-off point. The second panel from the top illustrates how the differential networks are computed from
the low and high networks using the sign-adjusted version. Different edge colors represent the edge weights of
opposite signs, but equal magnitudes, for simplicity. The bottom panel demonstrates how different sign-combinations
can be interpreted as type I or II interactions in the underlying parametric model. Moreover, the most important
arguments of the provided model_diffnet R-function are explained in the right panel to indicate their role in this
procedural flow.
https://doi.org/10.1371/journal.pcbi.1008960.g002
PLOS COMPUTATIONAL BIOLOGY Model guided trait-specific co-expression network estimation
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1008960 May 3, 2021 6 / 23
Simulation studies
The proposed method is evaluated and compared to the exhaustive search and GGM based
approaches through simulated scenarios. These examples are based on data provided by
DREAM9-challenge (organized in June 2014). This dataset [28] consists of 191 patients diag-
nosed with acute myeloid leukemia (AML) with measured expression levels of 231 proteins
and phosphoproteins probed by reverse-phase protein array analysis each of which is following
a standard normal distribution. New phenotypes are simulated conditionally on the expression
levels of these proteins to have a known phenotype regulation mechanism and realistic depen-
dencies between protein expression levels. We will use numeric subindexes 1, . . ., 231 to indi-
cate a specific protein in the DREAM-challenge dataset starting from the ACTB.
Model without the main effects. The simplest part of our simulation model contains
arbitrarily chosen six type I interaction terms controlling the variation of a normally distrib-
uted phenotype Y without any main effects. Also, more complex interactions of two different
types are incorporated into the model. First, we add two rectified linear unit (ReLU) terms
Δjk(Xij, Xik), defined to be equal to Xj Xk if Xj Xk�median(Xj Xk) and zero otherwise. At this
point, the simulation model is of the form:
Model A : YA ¼ X75X150 þ X100X200 þ X125X215 þ X25X52
þX33X66 þ X88X144 þ DðX12;X183Þ þ DðX109;X54Þ þ ε:
Ten replicates of the phenotype vector were simulated based on the above model with the pop-
ulation intercept of zero. The common residual variance s2ε was fixed to 1.75
2 for independent
and normally distributed (zero-centered) residual terms ε1, . . ., ε191 for each individual (the
simulated replicates are available at the Additional file 2).
We also use another interaction function Cþ=  ðXj;XkÞ to mimic disrupted interactions in
pathways among individuals with high or low phenotype values. These type of interactions are
simulated with respect to the variables Xj and Xk backward as follows: We first compute the
phenotype values Y = (Y1, . . ., Y191) for each individual based on the simulation model A. For
individuals with the phenotypic values larger than the 4/5 empirical quantile of Y, we overwrite
the expression values of the protein Xj as a function of the protein Xk to induce correlation
between them such that
Xik ¼ �Xij þ ε�i ; where ε
�
i � N ð0; 0:25
2Þ; ð4Þ
only if Yi� QY (2/3) and kept as original otherwise. In other words, such strong correlations
are present only among individuals with high phenotype values. A subindex in Cþ=  ðXj;XkÞ
denotes whether the induced correlation is positive or negative with reference to the
symbol ± in the Eq (4). We used this rule to generate the following interaction set over individ-
uals with phenotype values larger than the 4/5 empirical quantile of the phenotype vector
resulted from the simulation model A:
fC  ðX2;X170Þ; C  ðX50;X115Þ; C  ðX44;X99Þ; CþðX12;X180Þ; CþðX60;X125Þ; CþðX211;X222Þg:
Furthermore, we overwrite the expression values of the proteins X125 and X75 as a function of
the proteins X215 and X75 to induce strong correlation between them before the phenotypic
truncation such that
X125 ¼ X215 þ ε; where ε � N ð0; 0:25
2Þ;
X75 ¼ X150 þ ε; where ε � N ð0; 0:25
2Þ:
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The magnitudes of the induced correlations were approximately 0.95. These mimic the prob-
lematic collinearities between genes the interaction of which are important with respect to the
phenotype.
Applied methods. To evaluate the efficiency of the proposed dependency metric, we begin
by applying only the non-residual adjusted dPCCN approach: high and low groups are defined
with respect to the empirical median value of the original phenotype Y. As a comparison, we
estimate the sign-adjusted differential correlation co-expression networks (dCCN) in each sce-
nario also by using the simple correlation matrices instead of the proposed part-correlation
matrices. The same high and low groups are also used in the GGM based approach: The fused
graphical LASSO algorithm via the JGL R-package [12] is used to estimate the high and low
GGM networks and we refer to their difference as a differential GGM network (see [12] for
details and S1 Appendix for the tuning parameter selection). In the exhaustive search
approach, the interaction effects are estimated with the LASSO estimator [29] in which the
penalty parameter is chosen by the cross-validation criteria. As will be explained in the materi-
als and methods section, type I and II interactions are separated from each other by evaluating
from data whether or not |Fj,k| = 0 by using a user-specific threshold r> 0. Here we apply a
relatively small threshold r = 0.1 such that |Fj,k| is deemed to be zero if |Sj,k|< r.
Benchmarking. The evaluation and comparison are done by using the receiver operating
characteristics (ROC) curves [30]. The decision threshold value a is shifted over the range of
estimated network elements (or coefficient vector elements in exhaustive search) to produce
the true positive rate (TPR) and false positive rate (FPR) for each value of a such that
TPR ¼
The number of true positives
The number of positives
and FPR ¼
The number of true negatives
The number of negatives
:
Truncated (at 0.2 FPRs) and non-truncated areas under the ROC curves (AUCs) averaged
over the simulated replicates are displayed in Table 1 for each method (Model A columns).
Results. The most worrisome part of these results is a poor performance of the differential
GGM approach which deserves to be noted given its popularity and trending usage in gene-
gene interaction search—see e.g. [31]. The averaged non-truncated AUC is only 0.709. We like
to highlight that interpreting results in terms of typical parametric forms should be done with
caution when the differential GGM approach is applied. We argue that this problem is due to
the conditioning property, which in fact, is the main reason for GGMs’ popularity. A support-
ive example is given in S1 Appendix implying that their role in the differential network estima-
tion scheme should be characterized more specifically. Another concern is that the exhaustive
search approach does not have desired efficiency even though the model is relatively simple.
The averaged AUCs and truncated AUCs were 0.761 and 0.713.
Let us now consider the proposed sign-adjusted dPCCN. The improvement in performance
is tremendous in comparison to the reference methods—the non-truncated and truncated
Table 1. Simulation studies. Averaged areas under the truncated and non-truncated ROC curves (AUCs) over ten rep-
licates in the simulated scenarios without simulated main effects (Model A) and with additional main effects (Model
B). These datasets are analyzed using the proposed dPCCN procedure and dCCN method as well as the exhaustive
search and GGM model based approaches as reference methods.
Method A: AUC (0.2 FPR) A: AUC (1.0 FPR) B: AUC (0.2 FPR) B: AUC (1.0 FPR)
Sign dPCCN 0.869 0.915 0.793 0.835
Sign dCCN 0.631 0.600 0.534 0.500
Exh. search 0.713 0.761 0.537 0.597
dGGM 0.707 0.709 0.618 0.620
https://doi.org/10.1371/journal.pcbi.1008960.t001
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AUCs were 0.915 and 0.869. Firstly, this indicates that traditional interaction search
approaches suffer for more fundamental limitations than the lack of power and scalability that
are often the subjects of interest. In addition to a more flexible model in the parametric sense,
the use of tailored metrics to account for the inherent characteristics of gene-phenotype regu-
lation mechanisms is clearly of high importance. For instance, the sign-adjusted dCCN is con-
siderably less efficient in the above examples than the sign-adjusted dPCCN as expected.
Namely, the non-truncated AUCs for the sign-adjusted dCCN and dPCCN were 0.631 and
0.915. Of course, the sign-adjusted dCCN, by the definition would be more efficient for identi-
fying if a standard correlation coefficient is zero in the low group and non-zero in the high
group, or vice versa. However, it becomes inefficient for more challenging scenarios involving,
e.g., complex activation/deactivation patterns between genes. Thus, the proposed part-correla-
tion metric is an indispensable additional element if we want to identify interactions in the
estimation process.
Model with the main effects. In this example, the phenotype replicates are simulated oth-
erwise in the same way as in the previous example (using different replicates) but we also
incorporate six strong main effects into the model i.e.,




Here βj = 2 if j 2 {10, 30, 50, 70, 90, 100} and zero otherwise. In this case, we apply the residual
adjusted version of the sign-adjusted dPCCN method to account for the main effects. To esti-
mate the main effects, we used the elastic net estimator with α = 1/3 (a default value in the pro-
vided R-code) using the cross-validation based selection of the penalty parameter λ. Then,
high and low groups are defined with respect to the median of the estimated residual vector.
Results. The results of this analysis are also displayed in Table 1 (Model B columns). It
appears that the exhaustive search with truncated AUC of 0.537 and non-truncated AUC of
0.597 becomes unusable in this type of, fairly realistic, scenarios while the proposed residual-
and sign-adjusted dPCCN method remains remarkably efficient with truncated AUC of 0.793
and non-truncated AUC of 0.835 despite the simulated main effects. The differential GGM
approach is only slightly better than the exhaustive search—truncated AUC is 0.618 and non-
truncated AUC is 0.620. These simulated scenarios reveal huge benefits that could be achieved
with the proposed hybrid approach in comparison to the reference methods. This type of
hybrid approaches could truly open new avenues for interaction search and, as an additional
proof of concept, we illustrate its usage in a real acute myeloid leukemia example in the next
section.
Real data analysis—Acute myeloid leukemia
Acute myeloid leukemia (AML) is a hematological cancer of the myeloid line of blood cells
and the prognosis of this disease is poor with an extremely low 5-year survival rate [28]. The
recent advancements in high-throughput technologies have contributed to progress in leuke-
mia research and especially to predict survival times from gene expression profiles [32–34].
However, the majority of these studies have focused only on single genes or their additive
effects [4]. Although genetic interactions may help us better understand cancer biology and
the development of new therapeutic approaches [35], the effects of gene-by-gene interaction
on the survival times are not well known in cancers.
Survival time analysis. We apply the proposed framework for searching prognostically
valuable type I and II gene-by-gene interactions in AML. The same DREAM9 protein expres-
sion dataset is used as in the simulated examples but now the response variable represents real
PLOS COMPUTATIONAL BIOLOGY Model guided trait-specific co-expression network estimation
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patients’ survival times after diagnosis. Out of these 191 patients, 142 died during the follow up
with 77 weeks median survival time (quartile interval: [25, 103]).
We chose this survival analysis example to show that this method provides reasonable
results even with problematic/incomplete datasets. In this case, difficulties arise from the most
frequently appearing aspect of survival analysis, the right-censoring. This means that a patient
has left the study before death, i.e. Ci< Yi, where Ci denotes the time of censoring and Yi is the
actual survival time for an individual i [36]. There are 49 censored observations in the
DREAM9 dataset the most of which are above the median survival time (74 weeks) measured
from non-censored observations.
We must note that revealing the most hidden and important features of this data is not the
primary task here, and we are fully aware that some aspects might seem unreasonable from
that perspective. This example serves to provide one kind of practical example of cross-exploit-
ing the strengths of individual schemes to overcome the deficiencies of one and another.
Therefore, we chose to use intentionally a particularly problematic dataset, which also might
seem controversial on occasion.
In this case, for instance, we have to remove the censored observations for the network con-
struction step. This clearly induces bias to the results [36] if one aims to estimate the exact
effects of certain covariates on survival time. However, in this step, we aim to identify the most
important interaction terms associated with the survival time. As we are interest on the effects
sizes only on a relative level, we could tolerate a much higher amount of bias if we can ensure
that the overall procedure is conservative enough. This is done by switching back to the
parametric models, in which case the censored observations can be accounted for without
technical problems, e.g., via the log-rank test [36]. Thus, this validation step(s) is used to filter
out the false positives findings caused by the induced bias in the network estimation step.
In this example, we only apply the residual- and sign-adjusted version dPCCN method. The
main effects are estimated with the elastic net estimator [37] using α = 1/3 to obtain the esti-
mated residual vector with the penalty parameter λ chosen by the cross-validation (λ� 0.403).
Individuals are then divided into the high and low groups based on the median value of this
estimated residual vector (71 observations in each group). As explained in the materials and
methods section, type I and II interactions are separated from each other by evaluating from
data whether or not |Fj,k| = 0. To that end, we apply a relatively small threshold r = 0.1 such
that |Fj,k| is deemed to be zero if |Sj,k| < r.
The estimated differential network structures are displayed in Fig 3 where the interaction
types I and II are separated by green (type I) and red (type II) edges. Since the method itself is
unpenalized, we used a hard-thresholding procedure to produce sparsity into the resulting dif-
ferential network. For simplicity, the threshold value was chosen such that the number of net-
work edges is less than 70 for both interaction types. Yet, how to define the most optimal
threshold value is beyond the scope of this work.
Type I interactions. To show the explicit connection between the proposed framework
and an exhaustive search we parametrically test all genes connected with green edges. This is
done in accordance to the Aiken-West test [38]: A gene pair (Xk, Xl) is tested by regressing the
survival time Y on both individual genes and their interaction term, i.e., Y = Xk βk + Xl βl + Xk
Xl βkl over non-censored observations. At first, when testing the null-hypothesis of zero regres-
sion coefficients, the p-value associated with the interaction term should be relatively small.
Then, the interaction term is deemed relevant if the corresponding p-value is smaller than the
p-values associated with the main effects βk and βl.
Now 56 out of 67 interactions (� 84%) were also “positive findings” in terms of the Aiken-
West test. Note that we used this test to only illustrate the connection between the proposed
framework and an exhaustive interaction search. However, only two interesting type I
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interactions (highlighted in Fig 3) are considered in more detail as an example: Interactions
between RAC-alpha serine/threonine-protein kinase (AKT1) and cyclin E1 (CCNE1) as well
as between asparagine synthetase (ASNS) and the antibody phospho-gab2 (Tyr452) of
GRB2-associated-binding protein 2 (GAB2). The Aiken-West test results for these findings are
given in S1 Table.
Validation in an independent TCGA dataset. The validation of these two interaction
terms is based on the current literature and survival analysis performed in an another indepen-
dent AML cohort. This cohort includes RNA-sequencing for 173 AML patients with measured
expression levels of around 20 000 genes provided by The Cancer Genome Atlas (TCGA;
LAML data available at https://cancergenome.nih.gov/). RNA and protein expression levels
are expected to have a high correlation, but significant variation in correlation among genes
[39]. Thus, the validation of interaction terms derived from protein expression data of
DREAM9 in RNA expression level of TCGA is conservative, and suggests that the same inter-
actions are discovered using either one. However, the lack of congruence would not necessarily
invalidate the results derived from the other type of dataset due to different biological control
mechanisms of RNA and protein level expression.
To evaluate the prognostic power of these findings, all patients in TCGA dataset (including
censored observations) are classified into distinct gene-expression profile based risk-groups as
follows: If the expression value of the interaction term (CCNE1, AKT1) is below its qth quan-
tile, the patient is classified into the low-risk group (low-expression) and otherwise into the
high-risk group (high-expression). Note that the effects of gene-by-gene interactions (CCNE1,
AKT1) and (ASNS, GAB2.pY452) are of opposite signs. Thus, if the value of the interaction
Fig 3. Estimated differential networks. Estimated differential networks with the proposed residual- and sign-adjusted dPCCN approach in the
DREAM9-challenge protein expression dataset using the patients’ non-censored survival times (142 observations) as response. The interaction types I
and II are separated by green (type I) and red (type II) edges (plotted separately). A hard-thresholding was used to provide sparsity into the network
structures such that the number of network edges is less than 70 for both interaction types. The estimated network structures are displayed only for
connected nodes (with MiMI names) and the highlighted nodes indicate which network structures are discussed in detail.
https://doi.org/10.1371/journal.pcbi.1008960.g003
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term between (ASNS, GAB2.pY452) is above its (1 − q)th quantile, the patient is classified into
the low-risk group (high-expression) and otherwise into the high-risk group (low-expression).
We chose q to be 2/3 in order to emphasize the high-risk profiles. These gene-expression pro-
files are then analyzed via Kaplan-Meier analysis (Fig 4).
AKT1 and CCNE1. Constitutive phosphoinositide 3-kinase (PI3K) and AKT signaling are
repeatedly reported in AML studies [40]. However, there is considerable variation in the effect
of these pathway inhibitors among AML patients [41]. However, it might be that the prognos-
tic importance of AKT1 becomes crucial through the interaction with CCNE1 (Fig 4, left
panel) which plays a key role in cell proliferation [42]. Even though few studies [43, 44] has
mentioned the possible prognostic value of the expression of CCNE1, the accurate prognostic
role regarding CCNE1 has remained unclear. However, once we consider the interaction term
(AKT1 and CCNE1), high expression values (red curve) reduce median survival times clearly
in the TCGA dataset (Fig 4): Median survival times were 22 months in the low-risk group and
12 months in the high-risk group, respectively.
ASNS and GAB2. When the same expression profile based risk classification is done based
on the interaction term between ASNS and GAB2, median survival times were 26 months in
the low-risk group (high expression) and 12 months in the high-risk (low expression) group
using the TCGA dataset. However, it has been shown in [45] that high ASNS expression values
reduce survival times. In light of this example, it appears that we should be careful with such a
conclusion. Namely, already in the Aiken-West test performed in the DREAM9 dataset, we get
an indication that its prognostic importance in AML may be in its interactive nature with
GAB2 rather than as an independent prognostic factor (see S1 Table).
Combined risk classifier. We also illustrate how accurately these two interaction terms
together classify patients into high- and low-risk groups. Patients that are in the low-risk
group based on both interaction terms (AKT1, CCNE1) and (ASNS, GAB2) are classified into
the combined low-risk group. Respectively, patients that are in the high-risk group based on
both interaction terms are classified into the combined high-risk group. Other individuals are
removed. This classifier has remarkable accuracy even though it is based only on two interac-
tion terms. In the combined high-risk group (orange curve in Fig 4, right panel), the median
survival time is only 11 months in contrast to 46 months in the combined low-risk group (pur-
ple curve in Fig 4, right panel). Nearly three years difference in median survival times between
Fig 4. Survival analysis using type I interactions. Kaplan-Meier curves and the 95% confidence intervals for three
different classifiers in the TCGA dataset (173 observations). The first two panels represent the (AKT1, CCNE1)
interaction term based classifier and the (ASNS, GAB2) interaction term based classifier. Red and blue survival curves
correspond to high and low expression values. The last panel is a combined classifier; the low-risk group patients based
on both interaction terms (AKT1, CCNE1) and (ASNS, GAB2) are classified into the combined low-risk group (purple
curve) and into the combined high-risk group (orange curve) with the same logic. The p-values of the corresponding
log-rank tests are also reported.
https://doi.org/10.1371/journal.pcbi.1008960.g004
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the high- and low-risk groups (p-value� 0.00016) indicates that these findings have prognos-
tic value in AML.
Type II interactions. Type II interactions in Fig 3 cannot be tested explicitly using the
same parametric interaction test similar to the type I interactions. In general, the effects of
these type II interactions on a patient’s outcome can be relatively complex. Therefore, their
proper validation should be done always from the biological point of view which is beyond the
scope of this paper. Thus, we will rely on the current literature and select a few representative
examples that happen to share the same parametric form by which they can be used to separate
individuals into different risk groups.
Validation. It was interesting that the major parts of the signaling pathways known to
have a major impact on AML progression [46–49] are overlapping with the estimated network
structures. Based on these previously reported AML-related pathways, we select a smaller rep-
resentative subnetwork to be analyzed in more detail (highlighted in Fig 3).
Signal transducers and activators of transcription STAT3 and STAT5 are both downstream
effectors of several tyrosine kinase oncogenes including proto-oncogene tyrosine-protein
kinase SRC each of which are central nodes in the estimated network [50]. Interestingly, a par-
ticular kinase inhibitor drug based treatment (sorafenib) for AML has been shown [51] to
block SRC kinase-mediated STAT3 phosphorylation. The STAT5 activation, on the other
hand, is regulated by an interplay between SRC family kinases and the mammalian target of
rapamycin (MTOR) via AKT/MTOR signaling pathway [52]. These terms are closely related
in the estimated network through caspase-9 (CASP9) and integrin beta-3 (ITGB3). Moreover,
we like to bring forth that both ITGB3 and tripartite motif containing 62 (TRIM62) are bind-
ing the densest clusters together in the estimated network. This is particularly interesting due
to their possible interplay [53].
Further, STAT5 can interact with mediators of the PI3K/AKT signaling cascade which
plays a central role in the cancer cell survival [54]. This might explain other connections in the
estimated network. For instance, the downstream targets of the signaling pathway PI3K-AKT
include the BCL2-associated agonist of cell death (BAD) and CASP9 [55]. Furthermore, AML-
specific down-regulation of BAD/BCL2 plays a critical role in NOTCH-mediated apoptosis in
AML [56]. In our study, phosphorylated BAD (pS112) were associated with neurogenic locus
notch homolog protein 3 (NOTCH3) in the estimated network. The role of entire NOTCH
family, including NOTCH3, in AML is not well-understood and there have been conflicting
studies about its role in AML [56]. However, since the neighborhood of NOTCH3 appears to
be quite dense, it would be worth for further consideration.
We proceed by considering two STAT5 related examples more closely. To that end, we use
RNA sequencing expression data from the TCGA database via GEPIA [57] to illustrate the
prognostic power of these selected/representative pairs in an independent dataset.
Signal transducer and activator of transcription 3 and 5. STAT3 and STAT5 are both
members of the STAT protein family. STAT5 is consisting of two related proteins, STAT5A
and STAT5B, that share about 90% identity at the amino acid level [58]. As they are separated
in the validation dataset but not in the DREAM9 dataset, we analyze and validate all identified
interactions with respect to STAT5A and STAT5B separately.
STAT5 and SMAD3. SMAD family member 3 (SMAD3) is one of the receptor-regulated
effector proteins (R-Smads) in the transforming growth factor beta (TGFβ) signaling pathway
[59]. In particular, it is shown that ligand-induced activation of SMAD3 by the protein com-
plex activin and TGFβ leads to a direct inhibition of STAT5 transactivation [60]. Our results
suggest that this interplay between STAT5 and SMAD3 contains highly valuable prognostic
information. Using 20% and 80% cut-off points to classify high- and low expression ratio
groups in GEPIA, high STAT5/SMAD3 TPM ratios (Transcripts Per Million) were associated
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with more severe prognosis than low STAT5/SMAD3 TPM ratios with the p-value of 2.8 � 10−5
for STAT5B and 6.1 � 10−3 for STAT5A in the log-rank test (Fig 5). It also seems that this inter-
action term could not been found by typical parametric interaction tests. The parametric
Aiken-West test in the DREAM9 dataset gave a p-value of 0.476 when testing the null-hypoth-
esis of zero-valued effects.
STAT5 and PIM1. Expression levels of proto-oncogene serine/threonine-protein kinase
(PIM1) is known to be regulated by the JAK/STAT pathway involving both STAT3 and
STAT5 proteins [61]. When the interaction terms between PIM1 and STAT5 are tested with
GEPIA, high PIM1/STAT5B TPM ratios levels were more common with short survivals than
low PIM1/STAT5B TPM levels with p-value of 0.0025 in the log-rank test. Respectively, indi-
viduals with high PIM1/STAT5A TPM ratios had shorter survival times than with low PIM1/
STAT5A TPM ratios with the p-value of 0.083 in the log-rank test. Also in this case the
DREAM9 dataset was not conflicting with the null-hypothesis of zero-valued interaction effect
in the Aiken-West test (p-value of 0.326).
Discussion
The examples of this paper reveal a remarkable advance of the proposed approach over the
commonly used reference methods. However, even more important is to observe that the tra-
ditional exhaustive search approach and popularity gained GGM based differential networks
show a considerable lack of efficiency in the presence of typical attributes of gene/protein
expression data. In particular, the representative real prognostic analysis showed how impor-
tant interaction types might remain unidentified due to the limitations of common
approaches. The message of these results is therefore dual; we shared our observation about
the weaknesses of the mainstream methods but also provide a tailored alternative that has a
huge potential to open new avenues for interaction search with a significant impact on many
Fig 5. Survival analysis using type II interactions. Results from survival analysis including survival curves (and 95%
confidence intervals) and statistics using GEPIA software with 20% and 80% cut-off points to classify high- and low
expression ratio groups (21 individuals in both groups). In each panel, p-values of the log-rank tests are reported for
hypothesis tests of no differences between groups.
https://doi.org/10.1371/journal.pcbi.1008960.g005
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important fields like prognostic analysis. Due to the method’s ease of usage and flexibility for a
variety of biological data, we foresee the wide applicability of this method with immediate
practical relevance.
However, the proposed method is based on an explicit link between the elements of differ-
ential co-expression networks and parametric interaction models (presented in the materials
and methods section) only of the form (2) and relies heavily on zero-centered scaling of the
explanatory variables. By using this same framework, it would be interesting to see how a dif-
ferent kind of scaling of the explanatory variables would reflect the form of the underlying
model. Especially, it is an open question whether some scaling of the explanatory variables
would enable higher than second-order type I interactions to be identified in this framework
and what kind of dependency metric (in place of the proposed part-correlation metric) is
required for such purpose. These issues are beyond the scope of this paper and left for future
studies.
It is also noteworthy that we based the proposed approach on sample correlation/covari-
ance type matrices instead of popularity gained inverse correlation/covariance matrices i.e.
GGMs. However, this should not be considered as criticism against GGMs since they can obvi-
ously recover the co-expression networks much more efficiently than dCCNs exactly due to
the ability to distinguish these direct dependency from indirect ones. This is rather a matter of
purpose—the aim in the common differential network studies is to recover the gene co-expres-
sion patterns in two or more classes and compare the overall network dynamics in a more
causal sense between them. Here the focus is on mapping the parametric interaction model
into the pairwise dependencies between genes regardless of their conditional dependency
structure.
Moreover, the estimation of the inverse covariance matrix S−1 via maximum likelihood is
not possible when the empirical correlation matrix S is singular (for example when n< p since
rank(S)� n − 1). Some penalized estimators have been made for estimating the inverse covari-
ance matrix S−1 in the high-dimensional settings enabling non-singular, and even sparse
results. For example, applying the LASSO-penalty to the elements of Θ = S−1 leads to convex
optimization problem proposed in the paper of [62] enabling the inverse covariance matrix to
be estimated even if n< p. However, this increases computational complexity which is
between Oðp3Þ and Oðp4Þ for a row-by-row block coordinate method. Thus, one benefit of
using correlation co-expression networks instead of GGM based alternatives is their extremely
low computational complexity of learning.
Methods and models
Here we provide a synergistic framework based on parallel consideration of gene-by-gene
interaction models and novel quantitative trait-specific co-expression networks. In particular,
we address the following issues: (1) What is the explicit link between the co-expression net-
works and different types of parametric interaction terms? (2) How this link can be used to
derive an efficient and flexible trait-specific co-expression network estimation metric? (3)
How do we properly account for the inherent characteristics of gene-to-phenotype architec-
tures (e.g. strong main effects and collinearities between genes) in our network construction?
Co-expression network estimation schemes
There exist two major paradigms for constructing linear co-expression networks based on
unconditional (indirect) and conditional (direct) dependencies. The co-expression networks
representing unconditional relationships between genes are often defined by the covariance
(or correlation) matrix S. Such networks are referred as covariance/correlation co-expression
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networks (CCNs). For conditional co-expression network estimation, a popular option is to
use a inverse covariance/correlation matrix S−1 which is known and later referred as GGMs. It
has been shown that under the assumption of normality an element of S−1, say S  1j;k ; is zero, if
and only if genes Xj and Xk are conditionally independent given the rest of the genes [25].
However, we have shown that GGM based methods lack of efficiency for our purposes exactly
due to the conditioning property they are favored in the first place (see S1 Appendix). Thus,
our method is formulated only for the correlation/covariance co-expression networks.
Trait specific co-expression networks
Let us assume that the phenotype Y is regulated by the interaction model (2). We begin by
defining high and low groups of individuals based on the observed values Y1, . . .,Yn of the
quantitative phenotype Y such that:
• A high-group is consisting of individuals, whose phenotype values Yi fall into a critical
region, defined to be the top (1 − a) × 100% (a 2 ]0, 0.5]) highest values of phenotype among
all individuals, i.e., Yi� QY (1 − a), where QY (�) is a quantile function of the phenotype
distribution.
• For a low-group, a critical region corresponds the a × 100% lowest phenotype values i.e. a
control group is consisting of individuals to whom Yi� QY (a) holds.
The high and low groups are thereby conditioned to the corresponding tails of the pheno-
type distribution such that the magnitude of this conditioning depends on the a value. Note
that unless a equals to 0.5, individuals/samples between high and low groups are omitted from
the analysis so we prefer that a = 0.5. Let us proceed by introducing so-called truncated net-
work structures corresponding to the high and low groups:
• A high network G1−a = S1−a is constructed over individuals in a high group, i.e., to whom Yi
� QY (1 − a).
• A low network Ga = Sa is estimated over individuals, to whom Yi� QY (a) holds,
respectively.
However, we are not interested in the high and low networks as such but rather on the dis-
similarities between them as in [11, 12]. We therefore define a differential correlation co-
expression network (dCCN) structure as Ca = |S1−a − Sa| where the absolute value is taken
over the covariance/correlation matrix element-wise. The main idea will be first illustrated
with additional naive assumptions regarding the underlying model (2). When these assump-
tions are relaxed towards more realistic scenarios, new metrics are derived to modify data such
that these naive assumptions hold again.
Identifying interactions of type I and II
Determining a one-to-one correspondence between the type I interactions in the model (2)
and the differential networks is based on the following observation. Under certain conditions,
the dependencies in the high and low groups between two genes Xj and Xk are of different
signs with equal magnitudes if they form an important type I interaction term Xj Xk in the
model (2). Conversely, if Xj Xk is not an important interaction term of type I or type II, the
dependencies between Xj and Xk are equal to each other in the low and high groups. This
implies that there exists an edge between genes Xj and Xk (assuming that αjk = 0) in the corre-
sponding differential network only if the term Xj Xk is relevant type I interaction in the model
(2) (see the example (1) in S1 Appendix).
PLOS COMPUTATIONAL BIOLOGY Model guided trait-specific co-expression network estimation
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1008960 May 3, 2021 16 / 23
Respectively, correlation/covariance dependency-metric (CCN) specific type II interactions
of the model (2) are identified by distinguishing certain dependency patterns between genes in
the high and low groups (see also the example (2) in S1 Appendix) which is self-evident by
their definition. The following proposition (proposition 1—proved in S1 Appendix) character-
izes these statements more precisely.
Proposition 1 Let Saj;k and S
1  a
j;k denote the correlations between variables Xj and Xk in the
low and high groups. Let us use a specifying notation a�jk for the type II interaction effect of genes
Xj and Xk that contribute to the phenotypic variation through a linear co-expression relationship
which is associated only with high (or low) phenotypic values. We also assume that Xk and Xj are
independent before the phenotypic truncation (Assumption A) and that the main effects βk and
βj are zero in the model (2) (Assumption B). Then we have that:
• Invariant property: If the interaction term Xj Xk and the response variable Y are independent




j;k j ¼ 0.
• Property A1: If the interaction effect βjk in the model (2) is non-zero, and all type II interac-
tions among genes Xj and Xk are zero, then Saj;k ¼   S
1  a
j;k 6¼ 0.
• Property B1: If the effect βjk in the model (2) is zero and a�jk > 0 then jS
a
j;kj > 0 and S
1  a
j;k ¼ 0
or vice versa if a�jk < 0.
This proposition forms the basis for the explicit link between the model (2) and a new kind
of differential network estimation method introduced in the next section.
Sign-adjusted estimation
Here we present a sign-adjusted dCCN which exploits the properties A1 and B1 in the proposi-
tion (1) to categorize interaction types I and II in the estimation process based on the standard
correlation/covariance dependency metric. Let us consider a dCCN Ca = |S1−a − Sa| where the
truncated correlation matrices Sa and S1−a represent the low and high networks for some
truncation point a 2 ]0, 0.5] in relation to the model (2). Then the sign-adjusted dCCN Csgn,a
is defined as Csgn,a = Ca�P(S1−a, Sa) where� is an element-wise matrix multiplication oper-




1 if sgnðSaj;kÞ ¼   sgnðS
1  a
j;k Þ;
  1 if jSaj;kj > 0 and jS
1  a
j;k j ¼ 0;
  1 if jS1  aj;k j > 0 and jS
a
j;kj ¼ 0;
0 if jSaj;kj ¼ 0 and jS
1  a













The (j, k)th element of the sign-adjusted dCCN is denoted by Csgn,a(j, k). To evaluate from
data whether or not |Sj,k| = 0, we can perform a simple hypothesis test with an appropriate
Bonferroni correction [63] to account for the multiple testing problem. Alternatively, we could
simply apply a relatively small threshold r> 0 such that |Sj,k| is deemed to be zero if |Sj,k|< r
which is known as a hard-thresholding procedure [25].
While the regular dCCN (a simple difference of two correlation networks) captures the
effects in spurious form, the sign-adjusted dCCN characterizes the link between the differen-
tial network elements and the effects in the model (2) as follows:
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• (L1): If Csgn,a(j, k)> 0 then the associated type I interaction effect βjk is non-zero in the
model (2).
• (L2): If Csgn,a(j, k)< 0 then the associated type II interaction effect a�jk is non-zero in the
model (2).
• (L3): If Csgn,a(j, k) = 0 then both a�jk and βjk are zero in the model (2).
Note that the links L1-L3, at this point, rely on the naive assumption of the propositions (1-
2). Moreover, as dCCNs are based on standard correlation matrices, they are only capable of
identifying if genes are linearly dependent in one group but not in another. In the next sec-
tions, we generalize these ideas to be suitable in more realistic and complex scenarios.
Violation of the independence assumption
Let us consider the violation of the assumption (A) in the propositions (1-2). Differential co-
expression network type approaches including [11, 12, 31] are poorly capable of finding inter-
action terms Xk Xl when genes Xk and Xl are strongly correlated before the phenotypic trunca-
tion. This is due to fact that the high and low group construction cannot “break” the strong
dependency between two genes and therefore the property A1 in the proposition (1) does not
hold anymore as shown in S1 Appendix
Therefore, interaction terms are not identifiable if the correlation between genes is already
strong before the phenotypic truncation. The dependencies between genes before truncation
should be therefore accounted for by removing these dependencies in the estimation process.
A novel part-correlation metric




jjkÞ to remove linear
dependencies between genes Xj and Xk before the phenotypic truncation. Here εj|k is the resid-
ual resulting from regressing Xj against Xk in the non-truncated data. Each matrix element
F
a=1  a







εa=1  akjj ) for all 1� j, k� p (a/1 − a refers to high and low groups simultaneously). We call these
matrices as truncated part-correlation matrices to make clear difference to the partial correla-
tion/covariance matrices in which the conditioning is performed over all genes excluding the
pair Xj and Xk.
This seems rather counter-intuitive at first since the correlation between two variables after
removing the linear relationship between them is zero. However, now the assumption (A) in
the proposition (1) holds again and the systematic dependency behaviour described in the
property A1 remains between Xj and εj|k (or Xk and εk|j) when constructing the high and low
groups. Nevertheless, letFa and F1−a denote the truncated part-correlation matrices in the
low and high groups for some truncation point a 2 ]0, 0.5]. Then the part-correlation matrix
based differential network Qa (dPCCN) and its sign-adjusted version Qsgn,a with the truncation
point a 2 ]0, 0.5] are defined as
Qa ¼ jF
1  a   Faj and Qsgn;a ¼ Qa �PðF
1  a;FaÞ: ð6Þ
The (j, k)th elements of the dPCCN and sign-adjusted dPCCN are denoted by Qa(j, k) and Qa,
sgn(j, k). The following properties (the proof of which is given in S1 Appendix) are analogous
to the invariant and A1 properties in the proposition (1), except it only assumes that genes
involved in any phenotypically important interaction term do not have significant main effects
in the model (2).
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Proposition 2 LetFaj;k and F
1  a
j;k denote the part-correlations between variables Xj and Xk in
the low and high groups. Let us assume that the corresponding main effects βk and βj are zero in
the model (2). Then we have that:




• Property C1: If βjk 6¼ 0 and αjk = 0 in the model (2) then Faj;k ¼   F
1  a
j;k 6¼ 0:
In comparison to the dCCN version, the dPCCN method accounts for more complex acti-
vation/deactivation patterns between genes. However, the parametric forms of this kind of
type II interaction effects are more implicit (see S2 Appendix) than type II interaction effects
a�jk in the property B1, and need to be specified always case-specifically. Now the statements
L1-L3 hold for the sign-adjusted dPCCN elements Qa,sgn even if the assumption (A) does not.
However, so far the main effects of individual genes have not been accounted for. This signifi-
cantly undermines the possibility for interaction terms to be found for several reasons dis-
cussed in the next section.
Violation of the main effect assumption
Let us assume that some important type I interaction term Xj Xk is consisting of genes with
large main effects βj and βk in the model (2). In other words, the main effect assumption of the
previous propositions does not hold. However, it is required for the property A1 (see proof for




j Þ ¼ EðX
1  a
k Þ ¼ 0:
However, genes with strong main effects are linearly related to the phenotype by which high
and low groups are formed implying that this equality is not valid anymore. Another problem
is that the proportion of the phenotypic variation explained by the gene-gene interaction
might be insufficient for the interaction terms to be identifiable with small sample sizes [64–
66].
Residual step. The parallel consideration of the underlying parametric model (2) enables
an additional residual step to be used [64–66] by which the network estimation could be done
independently on the main effects: The main effects βk (k = 1, . . ., p) are first estimated in the
model (1) without the interaction terms to get the residual estimates




The estimated residual vector ε̂i is independent of the main effects and considered as a new










Here the random error ε�i;j of order two is assumed to follow a normal distribution with a
mean of zero and variance equal to s2
�
:Now instead of dividing individuals into the high and
low groups based on the original phenotype Yi we use the estimated residual values ε̂i : This
yields that the main effect assumption in the previous propositions can be assumed if the esti-
mated residual vector ε̂i is used as a response variable. Networks estimated by using this resid-
ual step are referred as residual-adjusted networks.
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